GAIN THERAPEUTICS, INC (GANX) Shareholders’ equity 2021–2024
GAIN THERAPEUTICS, INC (GANX) shareholders’ equity at each fiscal year-end, per SEC filings.
$12.6MFY2024 · since FY2021: $6.2M → $12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $12.6M | -33.4% |
| FY2023 | $18.9M | -45.8% |
| FY2022 | $34.8M | +461.4% |
| FY2021 | $6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice